Advertisement
Advertisement
NEPH
Nephros Inc.
2.79
USDSponsored
-0.30
-9.71%
Nov 06, 15:59 UTC -5
Closed
After-Market
2.76
-0.03
-0.97%
Nephros Inc. (NEPH) Earnings
NEPH Earnings Reports
Positive Surprise Ratio
NEPH beat 18 of 30 last estimates.
60%
Next Report
Date of Next Report
Mar 10, 2027
Estimate for Q4 26 (Revenue/ EPS)
$5.52M
/$0.01
Implied change from Q3 26 (Revenue/ EPS)
-1.79%
/-80.00%
Implied change from Q4 25 (Revenue/ EPS)
+16.71%
/-87.50%
Nephros Inc. earnings per share and revenue
On Nov 05, 2026, NEPH reported earnings of 0.05 USD per share (EPS) for Q3 26, beating the estimate of 0.02 USD, resulting in a 110.08% surprise. Revenue reached 5.62 million, compared to an expected 5.60 million, with a 0.33% difference. The market reacted with a -9.71% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.01 USD, with revenue projected to reach 5.52 million USD, implying an decrease of -80.00% EPS, and decrease of -1.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Accendra Health, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.01
Actual
-$0.23
Surprise
-2,177.23%
Bio-Rad Laboratories, Inc.Class A
Report Date
Nov 04, 2026 For Q3 26
Estimate
$2.24
Actual
$2.65
Surprise
+17.92%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
Phibro Animal Health Corporation Class A
Report Date
Nov 04, 2026 For Q1 27
Estimate
$0.81
Actual
$0.79
Surprise
-2.58%
Viemed Healthcare, Inc. Common Shares
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.12
Actual
$0.11
Surprise
-14.00%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
FAQ
What were Nephros Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Nephros Inc. reported EPS of $0.05, beating estimates by 110.08%, and revenue of $5.62M, 0.33% above expectations.
How did the market react to Nephros Inc.'s Q3 2026 earnings?
The stock price moved down -9.71%, changed from $3.09 before the earnings release to $2.79 the day after.
When is Nephros Inc. expected to report next?
The next earning report is scheduled for Mar 10, 2027.
What are the forecasts for Nephros Inc.'s next earnings report?
Based on --
analysts, Nephros Inc. is expected to report EPS of $0.01 and revenue of $5.52M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.